XML 32 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business segment information (Tables)
 9 Months Ended
Sep. 30, 2012
Schedule of External Net Sales for Continuing Operations by GBU

The tables below present external net sales for continuing operations by GBU reporting segment:

 

     External Net Sales by GBU  
     Three Months Ended September 30,  

(US$ in thousands)

    2012      2011      Reported
Growth		     Constant
Currency
Growth		  

Spine

           

Spine Repair Implants and Regenerative Biologics

    $ 36,634       $ 36,769         —   %      —   % 

Spine Regenerative Stimulation

      42,759         39,734         8 %      8 % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total Spine

      79,393         76,503         4 %      4 % 

Orthopedics

      35,359         40,803         (13 )%      (4 )% 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total Net Sales

    $ 114,752       $ 117,306         (2 )%      1 % 
  

 

 

     

 

 

     

 

 

    

 

 

  

 

     External Net Sales by GBU  
     Nine Months Ended September 30,  

(US$ in thousands)

    2012      2011      Reported
Growth		     Constant
Currency
Growth		  

Spine

           

Spine Repair Implants and Regenerative Biologics

    $ 110,892       $ 107,608         3 %      3 % 

Spine Regenerative Stimulation

      125,325         118,012         6 %      6 % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total Spine

      236,217         225,620         5 %      5 % 

Orthopedics

      114,069         121,416         (6 )%      1 % 
  

 

 

     

 

 

     

 

 

    

 

 

  

Total Net Sales

    $ 350,286       $ 347,036         1 %      3 % 
  

 

 

     

 

 

     

 

 

    

 

 

  
Operating Income (Loss) by GBU

The table below presents operating income (loss) for continuing operations by GBU reporting segment:

 

Operating Income (Loss) by GBU    Three Months Ended
September 30,		     Nine Months Ended
September 30,		  

(US$ in thousands)

    2012     2011     2012     2011  

Spine (1)

    $ 22,615      $ 22,373      $ 65,209      $ 28,239   

Orthopedics (2)

      3,274        4,501        12,347        5,842   

Corporate (3)

      (4,356 )      (3,275 )      (13,027 )      (18,583 ) 
  

 

 

    

 

 

    

 

 

    

 

 

  

Total

    $ 21,533      $ 23,599      $ 64,529      $ 15,498   
  

 

 

    

 

 

    

 

 

    

 

 

  

 

(1) For the nine months ended September 30, 2012 and 2011, the operating income for the Spine GBU included $1.5 million and $36.5 million, respectively, of expenses in connection with charges related to U.S. Government resolutions. For the nine months ended September 30, 2012, the operating income for the Spine GBU included a $3.1 million charge for an arbitration resolution related to a 2008 co-development agreement and a $2.3 million charge for costs related the Company’s strategic investment with MTF.
(2) For the nine months ended September 30, 2012 and 2011, the operating income for the Orthopedics GBU included $0.2 million and $6.5 million, respectively, of expenses in connection with charges related to U.S. Government resolutions. For the nine and three months ended September 30, 2012, the operating income for the Orthopedics GBU included a $0.7 million and $0.5 million charge, respectively, of costs related the Company’s strategic investment with MTF.
(3) For the nine months ended September 30, 2011, the operating loss for the Corporate GBU included $3 million of expenses in connection with charges related to U.S. Government resolutions and $3.2 million of senior management succession charges.